Due to the multiple roles of KChIP2 in regulating ion channels in the heart, a thorough understanding of the detailed molecular mechanisms by which abnormal KChIP2 levels increase arrhythmias susceptibility is key to the development of novel therapies for the prevention and treatment of cardiac arrhythmias. This evidence concerns the gene KCNIP2 and cardiac arrhythmia.